| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |